32,656,565 Equity Shares of Gland Pharma Limited are subject to a Lock-Up Agreement Ending on 18-NOV-2023. These Equity Shares will be under lockup for 1101 days starting from 12-NOV-2020 to 18-NOV-2023.

Details:
An aggregate of 20% of the fully diluted post-Issue Equity Share capital of the Company held by the Promoters namely Fosun Singapore and Shanghai Fosun Pharma, shall be locked-in for a period of 3 years from the date of Allotment.

The entire pre-issue capital of the company would be locked-in for a period of 1 year from the date of Allotment.